Dapagliflozin-3-O-beta-D-Glucuronide, CAS [[1351438-75-9]]

Produktübersicht

• Artikelname: Dapagliflozin-3-O-beta-D-Glucuronide, CAS [[1351438-75-9]]
• Artikelnummer: TGM-T35619
• Hersteller Artikelnummer: T35619
• Alternativnummer: TGM-T35619-1MG,TGM-T35619-500UG
• Hersteller: TargetMol
• Kategorie: Biochemikalien

Produktbeschreibung

Dapagliflozin-3-O-beta-D-glucuronide is a metabolite of dapagliflozin . Dapagliflozin is a first generation selective sodium glucose cotransporter (SGLT) 2 inhibitor that blocks glucose transport.[1] Dapagliflozin is metabolized by uridine diphosphate glucuronosyltransferase (UGT) 1A9 to dapagliflozin-3-O-beta-D-glucuronide, which is 2,600-fold less potent than the parent compound with regard to SGLT2 inhibition.[2]

Produkteigenschaften

• Molekulargewicht: 585
• CAS Nummer: [1351438-75-9]
• Formel: C27H33ClO12
• Target-Kategorie: Endogenous Metabolite|||Others

Bilder

T35619